Total Payments
$4,382
2023 Payments
$221.58
Companies
38
Transactions
230
Medicare Patients
2,386
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$4,084 (93.2%)
Education$297.67 (6.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,084 | 217 | 93.2% |
| Education | $297.67 | 13 | 6.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| OPKO Pharmaceuticals, LLC | $593.78 | 33 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $429.68 | 24 | $0 (2022) |
| Amgen Inc. | $259.25 | 10 | $0 (2022) |
| Mallinckrodt Hospital Products Inc. | $250.71 | 8 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $241.08 | 12 | $0 (2023) |
| Horizon Therapeutics plc | $221.55 | 12 | $0 (2023) |
| Daiichi Sankyo Inc. | $206.43 | 12 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $203.75 | 11 | $0 (2023) |
| Mallinckrodt Enterprises LLC | $201.11 | 14 | $0 (2019) |
| AKEBIA THERAPEUTICS INC | $186.68 | 11 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $221.58 | 12 | Travere Therapeutics, Inc. ($71.66) |
| 2022 | $710.39 | 28 | Bayer HealthCare Pharmaceuticals Inc. ($102.52) |
| 2021 | $998.81 | 52 | Horizon Therapeutics plc ($173.57) |
| 2020 | $348.21 | 21 | OPKO Pharmaceuticals, LLC ($76.56) |
| 2019 | $461.76 | 25 | OPKO Pharmaceuticals, LLC ($123.65) |
| 2018 | $877.50 | 46 | Vanda Pharmaceuticals Inc. ($203.80) |
| 2017 | $763.69 | 46 | Mallinckrodt LLC ($140.47) |
All Payment Transactions
230 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/12/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $26.82 | General |
| 08/14/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $7.98 | General |
| 08/07/2023 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: Rare Disease | ||||||
| 07/31/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $20.60 | General |
| Category: NEPHROLOGY | ||||||
| 05/03/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $5.27 | General |
| 04/19/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Cardio-renal | ||||||
| 03/30/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $23.40 | General |
| 03/28/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $8.19 | General |
| 02/17/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/02/2023 | AstraZeneca Pharmaceuticals LP | EVUSHELD (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Vaccines & Immune Therapies | ||||||
| 01/12/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $20.69 | General |
| Category: NEPHROLOGY | ||||||
| 01/05/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: KRYSTEXXA | ||||||
| 12/07/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Cardio-renal | ||||||
| 10/27/2022 | AstraZeneca Pharmaceuticals LP | EVUSHELD (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Vaccines & Immune Therapies | ||||||
| 09/15/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/25/2022 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: Hyperkalemia | ||||||
| 08/24/2022 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $20.06 | General |
| Category: NEPHROLOGY | ||||||
| 07/21/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: IMMUNOLOGY | ||||||
| 07/14/2022 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $14.48 | General |
| Category: NEPHROLOGY | ||||||
| 07/07/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Cardio-renal | ||||||
| 06/23/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Rare Disease | ||||||
| 06/17/2022 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $26.35 | General |
| Category: NEPHROLOGY | ||||||
| 06/09/2022 | Exeltis, USA Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 05/27/2022 | Watermark Medical, Inc. | ARES HOME SLEEP TESTING DEVICE (Device) | Food and Beverage | Cash or cash equivalent | $88.57 | General |
| Category: VENTILATORY EFFORT RECORDER | ||||||
| 05/26/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 356 | 907 | $224,816 | $116,724 |
| 2022 | 10 | 643 | 2,611 | $707,960 | $368,047 |
| 2021 | 11 | 665 | 2,545 | $712,585 | $389,827 |
| 2020 | 9 | 722 | 2,891 | $824,235 | $388,947 |
Total Patients
2,386
Total Services
8,954
Medicare Billing
$1.3M
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 208 | 479 | $77,814 | $43,356 | 55.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 41 | 152 | $79,800 | $42,959 | 53.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 32 | 146 | $25,550 | $14,185 | 55.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 45 | $11,250 | $6,385 | 56.8% |
| 90937 | Hemodialysis procedure requiring repeated evaluation | Facility | 2023 | 18 | 61 | $20,130 | $5,074 | 25.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 11 | 12 | $5,400 | $2,950 | 54.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 12 | $4,872 | $1,815 | 37.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 58 | 441 | $231,525 | $129,949 | 56.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 264 | 899 | $134,850 | $87,590 | 65.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 71 | 498 | $87,150 | $41,956 | 48.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 25 | 194 | $73,720 | $36,141 | 49.0% |
| 90937 | Hemodialysis procedure requiring repeated evaluation | Facility | 2022 | 40 | 303 | $99,990 | $25,938 | 25.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 69 | 119 | $29,750 | $19,278 | 64.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 27 | 57 | $25,650 | $13,964 | 54.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 40 | 40 | $7,800 | $4,757 | 61.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 36 | 37 | $8,325 | $4,662 | 56.0% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 13 | 23 | $9,200 | $3,811 | 41.4% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 64 | 543 | $285,075 | $161,093 | 56.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 272 | 910 | $136,525 | $91,291 | 66.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 77 | 446 | $78,050 | $38,928 | 49.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 83 | 151 | $37,750 | $25,565 | 67.7% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 36 | 84 | $37,800 | $20,263 | 53.6% |
| 90937 | Hemodialysis procedure with repeated evaluations | Facility | 2021 | 45 | 215 | $70,950 | $19,020 | 26.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 19 | 91 | $34,580 | $17,706 | 51.2% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2021 | 12 | 47 | $18,800 | $7,754 | 41.2% |
About Dr. Mohammad Zahid, MD
Dr. Mohammad Zahid, MD is a Nephrology healthcare provider based in Elgin, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1225027873.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammad Zahid, MD has received a total of $4,382 in payments from pharmaceutical and medical device companies, with $221.58 received in 2023. These payments were reported across 230 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($4,084).
As a Medicare-enrolled provider, Zahid has provided services to 2,386 Medicare beneficiaries, totaling 8,954 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Elgin, IL
- Active Since 10/17/2005
- Last Updated 09/08/2008
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1225027873
Products in Payments
- ACTHAR (Biological) $451.82
- Rayaldee (Drug) $351.01
- Kerendia (Drug) $241.08
- Auryxia (Drug) $227.64
- RAYALDEE (Drug) $224.49
- KRYSTEXXA (Biological) $221.55
- INJECTAFER (Drug) $206.43
- HETLIOZ (Drug) $187.46
- LOKELMA (Drug) $163.56
- Parsabiv (Biological) $131.83
- AURYXIA (Drug) $126.56
- REXULTI (Drug) $124.10
- Fanapt (Drug) $124.06
- Hetlioz (Drug) $118.16
- JYNARQUE (Drug) $116.20
- Veltassa (Drug) $100.81
- ARES HOME SLEEP TESTING DEVICE (Device) $88.57
- VRAYLAR (Drug) $77.00
- Trintellix (Drug) $72.45
- GATTEX (Drug) $67.85
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.